Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.07.23.666374

Genetic diversity unveiled: cost-effective methods for grassland species

Kaech, D.·Loera-Sanchez, M.·Studer, B.·Koelliker, R.
View original source ↗Export metadata ↓

Abstract

AbstractPermanent grasslands are predominantly composed of allogamous plant species that exhibit high levels of plant genetic diversity (PGD) within their populations. Grasslands with high PGD are more resilient to environmental stress and constitute valuable reservoirs of genetic resources for plant breeding. Therefore, monitoring PGD is the basis for detecting changes in PGD and correspondingly intervening. However, PGD monitoring is often neglected in biodiversity reports due to difficulties in taking representative samples and in using standardised and affordable indicators of PGD. Here we successfully applied two common approaches, multispecies amplicon sequencing (MSAS) and genotyping-by-sequencing (GBS), to assess PGD of agronomically relevant grassland species. Using MSAS, we were able to taxonomically distinguish five species (Dactylis glomerata L., Festuca pratensis Huds., Lolium perenne L., Trifolium pratense L., Trifolium repens L.) from multispecies samples and differentiate accessions within species, with fixation index (F ST) values ranging from 0.014 for T. repens to 0.089 for L. perenne. Based on an extended L. perenne sample set containing mixtures of two cultivars at different ratios, mixtures containing both cultivars at 50% separated from the corresponding cultivars according to this ratio using MSAS and GBS. Furthermore, GBS enabled separation of samples containing two cultivars at a 75:25-ratio from the corresponding cultivars and the 50:50-ratio samples. These results indicate complementing applications of the two approaches in PGD monitoring. While we anticipate that MSAS with its cost-effectiveness could be applied to large-scale PGD monitoring, GBS with its lower detection limit could be applied to studies where cultivar composition shifts are of interest.

Source connections

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kaech, D., Loera-Sanchez, M., Studer, B., Koelliker, R.. 2025-07-27. Genetic diversity unveiled: cost-effective methods for grassland species. https://doi.org/10.1101/2025.07.23.666374

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗
bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗